×

Noninvasive evaluation of liver fibrosis reverse using artificial neural network model for chronic hepatitis B patients. (English) Zbl 1423.92124

Summary: The diagnostic performance of an artificial neural network model for chronic HBV-induced liver fibrosis reverse is not well established. Our research aims to construct an ANN model for estimating noninvasive predictors of fibrosis reverse in chronic HBV patients after regular antiviral therapy. In our study, 141 consecutive patients requiring liver biopsy at baseline and 1.5 years were enrolled. Several serum biomarkers and liver stiffness were measured during antiviral therapy in both reverse and nonreverse groups. Statistically significant variables between two groups were selected to form an input layer of the ANN model. The ROC (receiver-operating characteristic) curve and AUC (area under the curve) were calculated for comparison of effectiveness of the ANN model and logistic regression model in predicting HBV-induced liver fibrosis reverse. The prevalence of fibrosis reverse of HBV patients was about 39% (55/141) after 78-week antiviral therapy. The Ishak scoring system was used to assess fibrosis reverse. Our study manifested that AST (aspartate aminotransferase; importance coefficient = 0.296), PLT (platelet count; IC = 0.159), WBC (white blood cell; IC = 0.142), CHE (cholinesterase; IC = 0.128), LSM (liver stiffness measurement; IC = 0.125), ALT (alanine aminotransferase; IC = 0.110), and gender (IC = 0.041) were the most crucial predictors of reverse. The AUC of the ANN model and logistic model was \(0.809 \pm 0.062\) and \(0.756 \pm 0.059\), respectively. In our study, we concluded that the ANN model with variables consisting of AST, PLT, WBC, CHE, LSM, ALT, and gender may be useful in diagnosing liver fibrosis reverse for chronic HBV-induced liver fibrosis patients.

MSC:

92C50 Medical applications (general)
92-08 Computational methods for problems pertaining to biology
PDFBibTeX XMLCite
Full Text: DOI

References:

[1] Lok, A. S. F., Chronic hepatitis B, New England Journal of Medicine, 346, 22, 1682-1683 (2002) · doi:10.1056/nejm200205303462202
[2] Zoulim, F.; Mason, W. S., Reasons to consider earlier treatment of chronic HBV infections, Gut, 61, 3, 333-336 (2012) · doi:10.1136/gutjnl-2011-300937
[3] Garcia-Tsao, G.; Friedman, S.; Iredale, J.; Pinzani, M., Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis, Hepatology, 51, 4, 1445-1449 (2010) · doi:10.1002/hep.23478
[4] Sebastiani, G.; Tempesta, D.; Fattovich, G., Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study, Journal of Hepatology, 53, 4, 630-638 (2010) · doi:10.1016/j.jhep.2010.04.019
[5] Thabut, D.; Trabut, J.-B.; Massard, J., Non-invasive diagnosis of large oesophageal varices with fibrotest in patients with cirrhosis: a preliminary retrospective study, Liver International, 26, 3, 271-278 (2006) · doi:10.1111/j.1478-3231.2005.01227.x
[6] Giannini, E. G.; Zaman, A.; Kreil, A., Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study, The American Journal of Gastroenterology, 101, 11, 2511-2519 (2006) · doi:10.1111/j.1572-0241.2006.00874.x
[7] Chen, J.; Pan, Q.-S.; Hong, W.-D., Use of an artificial neural network to predict risk factors of nosocomial infection in lung cancer patients, Asian Pacific Journal of Cancer Prevention, 15, 13, 5349-5353 (2014) · doi:10.7314/apjcp.2014.15.13.5349
[8] Bartosch-Härlid, A.; Andersson, B.; Aho, U.; Nilsson, J.; Andersson, R., Artificial neural networks in pancreatic disease, British Journal of Surgery, 95, 7, 817-826 (2008) · doi:10.1002/bjs.6239
[9] Ansari, D.; Nilsson, J.; Andersson, R.; Regnér, S.; Tingstedt, B.; Andersson, B., Artificial neural networks predict survival from pancreatic cancer after radical surgery, The American Journal of Surgery, 205, 1, 1-7 (2013) · doi:10.1016/j.amjsurg.2012.05.032
[10] Cross, S. S.; Harrison, R. F.; Kennedy, R. L., Introduction to neural networks, The Lancet, 346, 8982, 1075-1079 (1995) · doi:10.1016/s0140-6736(95)91746-2
[11] Darsey, J. A.; Darsey, J. A.; Griffin, W. O.; Joginipelli, S.; Melapu, V. K.; Cartwright, H., Architecture and biological applications of artificial neural networks: a tuberculosis perspective, Artificial Neural Networks. Methods in Molecular Biology, 1260 (2015), New York, NY, USA: Springer, New York, NY, USA · doi:10.1007/978-1-4939-2239-0_17
[12] Jahidin, A. H.; Megat Ali, M. S. A.; Taib, M. N.; Tahir, N. M.; Yassin, I. M.; Lias, S., Classification of intelligence quotient via brainwave sub-band power ratio features and artificial neural network, Computer Methods and Programs in Biomedicine, 114, 1, 50-59 (2014) · doi:10.1016/j.cmpb.2014.01.016
[13] Bagnasco, A.; Siri, A.; Aleo, G.; Rocco, G.; Sasso, L., Applying artificial neural networks to predict communication risks in the emergency department, Journal of Advanced Nursing, 71, 10, 2293-2304 (2015) · doi:10.1111/jan.12691
[14] Rushing, C.; Bulusu, A.; Hurwitz, H. I.; Nixon, A. B.; Pang, H., A leave-one-out cross-validation SAS macro for the identification of markers associated with survival, Computers in Biology and Medicine, 57, 123-129 (2015) · doi:10.1016/j.compbiomed.2014.11.015
[15] Karthikesalingam, A.; Attallah, O.; Ma, X., An artificial neural network stratifies the risks of reintervention and mortality after endovascular aneurysm repair; a retrospective observational study, PLoS One, 10, 7 (2015) · doi:10.1371/journal.pone.0129024
[16] Lopez-de-Andres, A.; Hernandez-Barrera, V.; Lopez, R., Predictors of in-hospital mortality following major lower extremity amputations in type 2 diabetic patients using artificial neural networks, BMC Medical Research Methodology, 16, 1, 160 (2016) · doi:10.1186/s12874-016-0265-5
[17] Wai, C.; Greenson, J. K.; Fontana, R. J., A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 2, 518-526 (2003) · doi:10.1053/jhep.2003.50346
[18] Vallet-Pichard, A.; Mallet, V.; Nalpas, B., FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection, comparison with liver biopsy and fibrotest, Hepatology, 46, 1, 32-36 (2007) · doi:10.1002/hep.21669
[19] World Health Organization, Guidelines for the Screening, Care and Treatment of Persons with Hepatitis B Infection (2015), Geneva, Switzerland: World Health Organization, Geneva, Switzerland
[20] Castera, L.; Pinzani, M.; Bosch, J., Non invasive evaluation of portal hypertension using transient elastography, Journal of Hepatology, 56, 3, 696-703 (2012) · doi:10.1016/j.jhep.2011.07.005
[21] Gurung, R. B.; Purbe, B.; Gyawali, P.; Risal, P., The ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT): the correlation of value with underlying severity of alcoholic liver disease, Kathmandu University Medical Journal, 11, 43, 233-236 (2013)
[22] Marcellin, P.; Gane, E.; Buti, M., Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study, The Lancet, 381, 9865, 468-475 (2013) · doi:10.1016/s0140-6736(12)61425-1
[23] Kong, Y.; Sun, Y.; Zhou, J., Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavir, Journal of Viral Hepatitis, 26, 5, 576-585 (2019) · doi:10.1111/jvh.13058
[24] Kim, W. R.; Berg, T.; Asselah, T., Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients, Journal of Hepatology, 64, 4, 773-780 (2016) · doi:10.1016/j.jhep.2015.11.012
[25] European Association for Study of Liver; Asociacion Latinoamericana parael Estudio del Higado; EASL-ALEH Clinical Practice Guidelines, Non-invasive tests for evaluation of liver disease severity and prognosis, Journal of Hepatology, 63, 1, 237-264 (2015)
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.